Antihypertensive medication Covid-19 hospitalization in total population Covid-19 hospitalization in total population Covid-19 hospitalization in total population Covid-19 hospitalization in total population 28-day mortality in Covid-19 patients 28-day mortality in Covid-19 patients 28-day mortality in Covid-19 patients 28-day mortality in Covid-19 patients 28-day mortality in hospitalized Covid-19 patients 28-day mortality in hospitalized Covid-19 patients 28-day mortality in hospitalized Covid-19 patients 28-day mortality in hospitalized Covid-19 patients
ntotal ncase OR (95%CI) OR (95%CI) ntotal ncase OR (95%CI) OR (95%CI) ntotal ncase OR (95%CI) OR (95%CI)
Simple model* Full model Simple model* Full model Simple model* Full model
ACEI 53796 387 Ref. Ref. 1888 111 Ref. Ref. 387 77 Ref. Ref.
ARB 30995 256 1.12 (0.95-1.31) 1.10 (0.94-1.29) 1196 97 1.47 (1.09-1.97) 1.49 (1.10-2.02) 256 57 1.28 (0.86-1.92) 1.31 (0.85-2.01)
ACEI 53796 387 Ref. Ref. 1888 111 Ref. Ref. 387 77 Ref. Ref.
CCB 36616 305 1.12 (0.96-1.30) 1.37 (1.17-1.60) 1396 97 1.23 (0.92-1.65) 1.35 (0.99-1.84) 305 66 1.19 (0.81-1.74) 1.21 (0.80-1.84)
ACEI 53796 387 Ref. Ref. 1888 111 Ref. Ref. 387 77 Ref. Ref.
BB 18878 258 1.82 (1.55-2.14) 1.53 (1.29-1.80) 789 104 1.93 (1.44-2.59) 1.80 (1.33-2.46) 258 68 1.39 (0.95-2.03) 1.43 (0.96-2.13)
ACEI 53796 387 Ref. Ref. 1888 111 Ref. Ref. 387 77 Ref. Ref.
Diuretic 19433 242 1.70 (1.44-2.01) 1.37 (1.16-1.63) 814 110 2.09 (1.56-2.80) 1.81 (1.32-2.46) 242 69 1.59 (1.08-2.35) 1.54 (1.01-2.34)
ACEI 53796 387 Ref. Ref. 1888 111 Ref. Ref. 387 77 Ref. Ref.
CCB/BB/Diuretic 38691 366 1.32 (1.14-1.52) 1.63 (1.40-1.90) 1485 137 1.56 (1.19-2.05) 1.64 (1.23-2.19) 366 90 1.31 (0.92-1.86) 1.37 (0.93-2.01)